Cargando…
Combined targeting of pathways regulating synaptic formation and autophagy attenuates Alzheimer’s disease pathology in mice
All drug trials completed to date have fallen short of meeting the clinical endpoint of significantly slowing cognitive decline in Alzheimer’s disease (AD) patients. In this study, we repurposed two FDA-approved drugs, Fasudil and Lonafarnib, targeting synaptic formation (i.e., Wnt signaling) and ce...
Autores principales: | Bjorkli, Christiana, Hemler, Mary, Julian, Joshua B., Sandvig, Axel, Sandvig, Ioanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426773/ https://www.ncbi.nlm.nih.gov/pubmed/36052130 http://dx.doi.org/10.3389/fphar.2022.913971 |
Ejemplares similares
-
Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
por: Bjorkli, Christiana, et al.
Publicado: (2020) -
Selective inhibition of excitatory synaptic transmission alters the emergent bursting dynamics of in vitro neural networks
por: Weir, Janelle Shari, et al.
Publicado: (2023) -
Connectomics of Morphogenetically Engineered Neurons as a Predictor of Functional Integration in the Ischemic Brain
por: Sandvig, Axel, et al.
Publicado: (2019) -
Editorial: Criticality in neural network behavior and its implications for computational processing in healthy and perturbed conditions
por: Sandvig, Ioanna, et al.
Publicado: (2022) -
Silencing of Activity During Hypoxia Improves Functional Outcomes in Motor Neuron Networks in vitro
por: Fiskum, Vegard, et al.
Publicado: (2021)